Actuarial consultancy and research house Rice Warner has pointed to the likelihood of further superannuation fund mergers.
In an analysis published this month, the company has pointed to recent merger activity and the likelihood of further moves based on the number of not for profit funds with less than $2 billion in funds under management (FUM).
It pointed to the mergers of Kinetic into Sunsuper, Rio Tinto Staff Super into Equipsuper, the sale of the ANZ superannuation business to IOOF, the merging of Tasplan with the Tasmanian RBF Accumulation Scheme and the AON Master Trust merger with Equity Trustees.
“Yet, we still have a long way to go,” the Rice Warner analysis said and pointed to its research which had revealed that there were 79 not-for-profit funds with less than $2 billion.
“This is the same cash flow that AustralianSuper receives every 4 months,” it said. “Below that level, funds have higher operational costs and much thinner resources. These funds will not be viable in future so they need a growth strategy.”
The Rice Warner analysis said that, as a consequence, the industry could expect the same reduction in funds (60 per cent) in this decade.
“That will still give us 55 not for profit funds and a smaller number of retail funds,” it said. “In the latter case, the number of funds is partly a reflection of legacy products and we can expect that many will merge under the same corporate trustee.”
“This will provide a vibrant market with plenty of choice,” the analysis said.
Jim Chalmers has defended changes to the Future Fund’s mandate, referring to himself as a “big supporter” of the sovereign wealth fund, amid fierce opposition from the Coalition, which has pledged to reverse any changes if it wins next year’s election.
In a new review of the country’s largest fund, a research house says it’s well placed to deliver attractive returns despite challenges.
Chant West analysis suggests super could be well placed to deliver a double-digit result by the end of the calendar year.
Specific valuation decisions made by the $88 billion fund at the beginning of the pandemic were “not adequate for the deteriorating market conditions”, according to the prudential regulator.